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Abstract
A simplistic multifactorial model was crafted to represent change in plasma glucose concentrations after
increases in stress hormones above baseline. A sample application of the predictive use of this model was
demonstrated, and a reflection on possible models in diabetic populations was described. The potential for
use of this model in conjunction with current models is discussed, as well as the issues pertinent to such a
basic model.
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PROBLEM STATEMENT 
Many mathematical models for diabetes exist, including complex arrays of variables that 
affect plasma blood glucose. While there is a clear understanding that stress hormones increase 
blood glucose, the author is not aware of mathematical models specifically delineating the 
mechanism for stress hormones to increase plasma blood glucose. This problem can be addressed 
through a basic multifactorial model, which can potentially be applied by those at risk for 
hyperglycemia in the face of stressful events or as a result of particular medications. 
MOTIVATION 
     Stress of any form affects the human body in a multitude of ways, one of which being that it 
prompts the release of hormones which support the body in handling difficult situations. Those 
with certain health conditions, such as diabetics, must pay special attention to the way that stress 
may impact their health. Stress hormones including cortisol, epinephrine, and norepinephrine 
all—among other things—act to increase the amount of plasma glucose ready for use during 
urgent situations (Marcovecchio and Chiarelli, 2009). Even glucagon is considered a stress 
hormone that works to that end, outside of its role as a remedy for hypoglycemia (Jones, Tan, 
and Bloom, 2012). 
     The human body has complex metabolic pathways for the digestion, storage, and use of 
glucose, which are critical for any individual to have enough energy to carry out many other 
processes, seeing that glucose is the most direct fuel that the body can use (Smith et al., 2009). 
Once glucose is introduced in the blood stream from the digestive system, it will reach a variety 
of destinations. Tissues in the body which require insulin to process glucose become problematic 
for diabetics, since the main feature of diabetes is elevated blood glucose levels, hyperglycemia, 
from improper transport of glucose from the bloodstream into cells. This generally takes the 
form of an inability to produce insulin, type 1 diabetes, or an otherwise impaired utilization of 
insulin, type 2 diabetes (Hernandez, 2016). 
      In a nondiabetic, glucose travels in and out of tissues according to a negative feedback 
mechanism involving insulin, so that an ideal level of free-floating plasma glucose is sustained 
and available for use (Zullo, 2009). However, when the body experiences stress, the sympathetic 
nervous system is activated to deal with emergencies by a “fight or flight” mechanism, and part 
of this activation involves the secretion of stress hormones which stimulate a higher rate of 
glucose release into the blood (The Science of Stress). Similarly, it is known that taking 
medicines related to stress hormones, such as glucocorticoids, can increase diabetes risk by 
altering the individuals’ usual glucose levels (Hwang and Weiss, 2014). 
     There are a plethora of models describing the ins and outs of glucose with regards to insulin 
secretion, insulin sensitivity, glucose absorption, glucose secretion, physical activity, and so on, 
but the author is not aware of a model describing the way stress hormones also affect blood 
sugar. Although plenty of research on the subject exists, and although its principles may seem 
relatively simple, it may be helpful to construct a basic mathematical model also including the 
mechanism of these hormones to affect blood glucose. Writing a multivariate function for this 
feature of glucose metabolism could help establish a basic reference of how changes in stress 
levels or the intake of certain medications may alter future glucose levels in an individual. 
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MATHEMATICAL DESCRIPTION AND SOLUTION APPROACH 
A Simplistic Multivariate Model of Change in Plasma Glucose by Stress Hormones 
 
     Based on information from “Role of Counterregulatory Hormones in the Catabolic Response 
to Stress” by Gelfand et al., 1984, I proposed a simple mathematical model of how four stress 
hormones affect plasma blood glucose: 
 
𝐺 (𝑐, 𝛼, 𝑒, 𝑛) = 𝐺𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒[1 +
0.2𝑐
6 𝑚𝑔(𝑚−2ℎ−1)
+
𝑝1𝛼
4 𝑛𝑔(𝑘𝑔−1𝑚𝑖𝑛−1)
+
𝑝2𝑒
0.6 𝜇𝑔(𝑚−2𝑚𝑖𝑛−1)
+
𝑝3𝑛
0.8 𝜇𝑔(𝑚−2𝑚𝑖𝑛−1)
]               (1) 
 
In function (1), the variables represent stress hormones present above normal levels, where “c” is 
cortisol, in mg(m-2h-1), “α” is glucagon, in ng(kg-1min-1), “e” is epinephrine, in µg(m-2min-1), and 
“n” is norepinephrine, in µg(m-2min-1). Each variable is divided by its units in values mirroring 
the infusion rates stated in the Gelfand et al. article. This serves to normalize each variable, so 
that what is being shown from each component is not the actual rate of infusion, but a standard 
unit describing how much of each hormone is present above baseline levels. Ignoring the 
coefficient in the numerators, the variables will cancel to a value of 1 in the case of severe stress 
which constitutes the levels of each variable shown in the denominators. Likewise, units of these 
variables cancel with their denominators in the function. Plasma glucose, “G” may be reported in 
either mg/dL or mmol/L, and “Gbaseline” is a constant that represents an individual’s normal level 
of plasma glucose in the absence of abnormal stress. 
     Each hormone is given a coefficient based on the proportion it could contribute to a rise in 
blood sugar after secretion. In the Gelfand et al. study, the only hormone whose effect on glucose 
was measured on its own was cortisol, which raised plasma glucose from 20% to 25% after 
being infused at the rate shown in the denominator of its part of the function. The average rise in 
glucose due to all hormones being infused together was reported between 60% and 80%. Since it 
is not clear what percentage glucagon, epinephrine, or norepinephrine raised blood glucose 
individually within this, they were initially given placeholders of “p1”, “p2”, and “p3” 
respectively. Focus was placed on the minimum possible value of a 60% overall rise in plasma 
glucose and after cortisol was given a coefficient of 0.2 for 20%, the remaining 40% was evenly 
distributed among the other hormones: 
 
𝐺 (𝑐, 𝛼, 𝑒, 𝑛) = 𝐺𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒[1 +
0.2𝑐
6 𝑚𝑔(𝑚−2ℎ−1)
+
0.133𝛼
4 𝑛𝑔(𝑘𝑔−1𝑚𝑖𝑛−1)
+
0.133𝑒
0.6 𝜇𝑔(𝑚−2𝑚𝑖𝑛−1)
+
0.133𝑛
0.8 𝜇𝑔(𝑚−2𝑚𝑖𝑛−1)
] ≥ 0         (2) 
 
Function (2) must be either zero or positive since all variables, including 𝐺𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒 describe some 
concentration of chemical, and it is not possible for such concentrations to be negative in the real 
world. 
 
Application of the Model 
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     Since this model assumes a constant baseline glucose, it is only practically applicable for 
nondiabetic individuals. If such an individual normally has a steady glucose level of 80 mg/dL 
and is to start a medication regimen that increases his or her circulating cortisol levels to half of 
the standardized rate, 3 mg(m-2h-1), leaving other hormones unaffected, the following would be 
shown: 
 
𝐺 = 80
𝑚𝑔
𝑑𝐿
[1 +
0.2(3𝑚𝑔(𝑚−2ℎ−1))
6 𝑚𝑔(𝑚−2ℎ−1)
+
0.133(0)
4 𝑛𝑔(𝑘𝑔−1𝑚𝑖𝑛−1)
+
0.133(0)
0.6 𝜇𝑔(𝑚−2𝑚𝑖𝑛−1)
+
0.133(0)
0.8 𝜇𝑔(𝑚−2𝑚𝑖𝑛−1)
]       (3)                                                                                                     
 
It is assumed there are no increases in glucagon, epinephrine, or norepinephrine above baseline 
levels, so that α, e, and n are 0. Completing the calculations in (3) results in (4): 
 
𝐺 = 80
𝑚𝑔
𝑑𝐿
[1 + 0.2(0.5)] = 80
𝑚𝑔
𝑑𝐿
[1.1] = 88
𝑚𝑔
𝑑𝑙
 .                                                            (4) 
 
Where, predictably, only half the amount of cortisol present in severe stress is circulated, so that 
the blood glucose is raised 10% from baseline, rather than 20%. 
 
In the Case of Diabetics 
 
     Diabetics particularly type 1 diabetics, lack the negative feedback mechanism which keeps a 
nondiabetic’s plasma glucose relatively constant. This mechanism also helps to cap off increases 
in stress hormones to only what is necessary, since these are the hormones responsible for raising 
blood glucose as needed.  
     In a case where a diabetic lacks delivery of any exogenous insulin, one could theorize that 
rises in stress hormones would trigger a catastrophic positive feedback mechanism. In such a 
loop, stress would feed into stress hormones, which would feed into elevated glucose levels, 
which would feed back into stress: 
 
 
 
Figure 1. Diagram representing the positive feedback loop in uncontrolled type 1 diabetes. 
 
     As glucose is not being fed into cells, extra solute in the blood increases risk for dehydration, 
among other issues. Additionally, the fact that practically no fuel is being delivered to deal with 
the initial stressor lends to more production of hormones to continue to try to remedy the issue. 
This increases the concentration of blood glucose to unhealthy levels and only makes the 
condition worse. 
     Such a positive feedback mechanism could be represented by the logistic growth equation, in 
which levels of these components will rise through time until they reach a threshold where 
continued growth is no longer feasible. However, experimentally gathering data on an upper 
limit to glucose levels in the absence of insulin would be difficult since such an endeavor would 
Elevated Stress
Elevated Stress 
Hormones
Elevated 
Glucose
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be incredibly risky to participants, and thus unethical.  Perhaps in the future, studies on small 
rises in blood sugar, sans insulin, over extremely short periods of time could potentially be used 
to create models of the feedback loop without much risk to participants. 
 
DISCUSSION 
A Simplistic Multivariate Model of Change in Plasma Glucose by Stress Hormones  
 
     While the model (1) presented here seems rather straightforward, some notes should be made 
about the research data used to construct this mathematical model. In addition to the Gelfand et 
al. study, experiments need to be carried out to ascertain what proportions of a total rise in 
glucose are accounted for by the stress hormones discussed—namely glucagon, epinephrine, and 
norepinephrine. For some reason, singular attention was paid to cortisol’s responsibility in 
affecting glucose. Consequently, only cortisol’s role in the function is accurate to the data. An 
assumption of the other hormones’ equal contribution to changes in plasma glucose may be 
completely false. Perhaps one of the three hormones mentioned plays an even larger role than 
cortisol, affecting glucose up to 40%, while the others contribute scantly. There is no way to 
know that relationship between these variables without more distinct experimental data. 
     Furthermore, the Gelfand et al. study only used a small number of obese subjects, primarily 
female (1984, p. 2239). Such a limited population sample means that the study, and thus this 
model based on its data, may lack external validity. Another worry is that the study is quite old. 
Over 3 decades have passed since its publication, and more current knowledge of the matter at 
hand should be sought out. 
 
Application of the Model 
 
     Such a direct model allowing us to calculate glucose concentrations in response to stress 
hormones may be an oversimplification of the physiology at work. The relationship between 
elevating stress hormones and resulting plasma glucose levels may not be as obvious as it may 
seem. Once again, there is a need for more experimental data and an evaluation of existing 
research on the mechanism by which hormones such as cortisol navigate the body, and whether 
other chemicals may interfere with cortisol’s role in elevating blood glucose. 
     Even with potential issues, components of this model should be implemented into existing 
models of the insulin-glucose feedback system. In 2000, Tolić, Mosekilde, and Sturis, presented 
their comprehensive models of the insulin-glucose system using differential equations, with the 
following equation representing the rate of change in plasma/intercellular glucose at any one 
time: 
𝑑𝐺
𝑑𝑡
= 𝐺𝑖𝑛 − 𝑓2(𝐺) − 𝑓3(𝐺)𝑓4(𝐼𝑖) + 𝑓5(𝑥3) .                                                    (5) 
 
In (5), the “f” values are appended functions which mediate different aspects of glucose uptake 
and secretion. Of particular interest is the last one: 
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𝑓5(𝑥3) =
𝑅𝑔
1+𝑒
𝑎(
𝑥3
𝑉𝑝−𝐶5
)
 .                                                                           (6) 
 
Function (6) represents hepatic (liver) production of glucose considering opposing effects from 
one of the insulin delay variables in the model (Tolić et al., 2000, pp. 363-364). Note that the “a” 
is changed from the original “α” in the Tolić  et al. text, in order to avoid confusion with the 
different variable established earlier. The simple model presented in this paper represents that 
extra glucose released into plasma—including from the liver—is stimulated by stress hormones. 
The parameters given by the researchers for the above function appear to show that all values 
present are constants except for “f5 ” (hepatic production) and “x3”, representing an effect of 
insulin delay (Tolić et al., 2000, p. 363). Certainly there must be a way to attach the linear, 
multifactorial model of stress hormones onto this to better represent hepatic production, which is 
controlled by more than just insulin delays. 
 
In the Case of Diabetics 
 
     Diabetes, being a problem of elevated and variable blood sugar concentrations, does not fit 
with the model presented here, which depends on a constant baseline glucose level as part of the 
function. Additionally, stress models involving diabetics are expected to have issues with 
accuracy over the long run. The longer an individual has diabetes, the more deteriorated their 
stress hormone response becomes (Dr. Andrew D. Henry, 2016). This means that over time, 
diabetics will not fit into given models as well, and so cannot refer to them reliably. 
     The positive feedback loop discussed as the natural trend of type 1 diabetics lacking insulin is 
an interesting point for future study. Possible applications of such a model would be to give a 
more defined idea of what happens in completely uncontrolled diabetes, what the timeline for 
acute hyperglycemic emergencies might be, and to shed light on the implications of stress to 
create persistent hyperglycemia when not properly addressed in a treatment regimen. Once again, 
designing studies to effectively determine the mechanism without hurting participants is a 
priority. Surpassing risks, however, is some potential benefit to understanding appropriate 
models that fit nondiabetics more realistically. 
CONCLUSION AND RECOMMENDATIONS 
     Using data from a 1984 study by Gelfand et al., a rudimentary multivariate model was 
crafted to represent change in plasma glucose concentrations in response to increases in 
stress hormones above baseline. The model successfully allowed for the estimation of blood 
glucose levels after input of an artificial amount of excess cortisol. The model’s reliance on 
limited data, simplicity, and restriction to nondiabetics are issues. Nevertheless, the author 
is hopeful and recommends that a model like this be fused with current models to show how 
stress hormones play a significant role in glucose levels. 
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